Medical Oncologist, Royal Brisbane and Women's Hospital,
IMDC Fellow (2019-2021)
Feb 13, 2021 • 9 tweets • 6 min read
What a fantastic way to end #GU21! A year ago, I attended my 1st #ASCOGU. A year on, I am so grateful to all pts, #IMDConline collaborators, @ASCO, & @DrDanielHeng for the opportunity to present the outcomes of 1L IO Combos in mRCC.
@OncoAlert@DrChoueiri@ShaanDudani@montypal
1/723 pts were included. IPI-NIVO group had a higher proportion of pts with worse IMDC risk profile, compared to IOVEGF group. We have to interpret the data in this context.